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EXECUTIVE SUMMARY
This multidisciplinary expert panel was convened to generate recommendations to address the limited 
access to care that patients experience when taking opioids for chronic pain. Recent policies and 
guidelines instituted to reduce inappropriate opioid prescribing have had unintended consequences 
for the 5-8 million patients taking long-term opioid therapy for chronic pain in the U.S. As providers 
discontinue prescribing and turn away patients dependent on opioids, this population faces limited 
access to both primary and pain-related care. The root causes of this access issue can be attributed 
to several overarching barriers, including new opioid-related policies, payment models, a lack of care 
coordination, stigma, and racial biases.
Over multiple rounds of deliberation, the panel brainstormed possible solutions, considering feasibility, 
impact, and importance, and ultimately ranked their final recommendations in order of implementation 
priority. The final list included 11 recommendations, from which three overarching themes emerged:  
Improving care models to better support patients with chronic pain
Three recommendations involved improving care models, including the top two: increasing 
reimbursement for the time needed to treat complex chronic pain and establishing 
coordinated care models that bundle payments for multimodal pain treatment. 
Enhancing provider education and training
Four recommendations involving provider education efforts received slightly lower rankings 
and included training on biopsychosocial factors of pain care and clarifying the continuum 
between physical dependency and opioid use disorder.
Implementing practices to reduce racial biases and inequities
The remaining four recommendations address racial biases and inequities, ranging from 
standardizing pain management protocols to reduce bias to increasing recruitment and 
retention of providers from underrepresented racial minorities.
Throughout the process, panelists emphasized the interconnectedness of their proposed solutions, 
and indicated that multiple approaches are likely needed to meaningfully improve access to care for 
this patient population. Importantly, though this panel was convened in Michigan, and its expertise 
grounded in Michigan’s healthcare ecosystem, there are millions of patients taking opioids for 
chronic pain across the country, and reports of limited access to care are not unique to Michigan. 
Consequently, there may also be opportunity to apply these recommendations more broadly, in other 
states and at multiple levels of the United States healthcare system.
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1.1 BACKGROUND: UNINTENDED CONSEQUENCES
Drug-related overdoses continue to climb in the U.S., with an estimated 90,000 deaths in 2020,1,2 
despite a decades-long, nationwide effort to limit and reverse rising numbers of opioid-related deaths. 
In recent years, numerous states have passed laws to combat opioid-related harms by reducing 
inappropriate prescribing. These laws require specific clinical practices, such as mandatory checks of 
prescription drug monitoring programs, and place strict limits on dosages and durations prescribed.3 
The enactment of these policies has been associated with declines in opioid prescribing,4 but many 
stakeholders have expressed concern that such broad efforts may also be unintentionally leading 
providers to restrict ethical care for patients receiving long-term opioid therapy (LTOT) for chronic 
pain. As a result, these patients may face inappropriately rapid tapering or discontinuation of their 
dosages and uncontrolled pain.5,6 Though there has been significant attention and funding directed to 
preventing and improving care for patients with opioid use disorder (OUD), there has been relatively 
less attention paid to these “forgotten” patients with chronic pain on LTOT. 
Nationally, an estimated 5-8 million adults receive LTOT to treat chronic pain.7 In response to state 
and federal laws that limit and sanction opioid overprescribing, some physicians have reduced or 
stopped prescribing opioids. This has been associated with reports of patients—who have developed 
physical dependence on opioids—struggling to find new providers willing to treat them.8,9 Recent 
studies, both in the State of Michigan and nationally, have found that over 40% of primary care 
clinics would not accept a new patient who was taking opioids for chronic pain.10,11 This situation can 
be emotionally distressing, both for patients, who may confront withdrawal and uncontrolled pain 
without being able to find a new provider, and physicians, who may feel ill-equipped to provide care to 
patients taking opioids for chronic pain.
Below is an example of how barriers to care might arise for a patient receiving long-term opioid 
therapy: 
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Mrs. Smith, a 65-year-old, started receiving oxycodone for a back injury 7 years ago and is now taking 
high doses. She also has co-morbid depression and diabetes that are managed by her primary care 
clinic. Dr. Johnson is concerned that Mrs. Smith may be misusing her prescriptions because she 
calls frequently to request early refills. Mrs. Smith, however, attributes requesting early refills to her 
worsening pain, which led her to take more than the prescribed number of pills. 
Dr. Johnson feels that he does not have the time or skills to safely manage Mrs. Smith’s opioid 
prescription for her pain and states that he will no longer prescribe opioids to Mrs. Smith. Mrs. Smith 
feels abandoned and frightened by this decision. She calls two primary care clinics to see if she can 
find a new doctor and is notified that they are not taking new patients on opioids. She calls a pain clinic 
and is told that they do not have openings for patients who “need pills” and are only accepting new 
patients with a referral for procedures like injections. She does not seek behavioral health support, such 
as addiction services, because she does not identify herself as having a substance use disorder. 
Patients with pain also face barriers to receiving non-opioid pain treatments, such as behavioral 
health and non-pharmacologic pain care. According to a 2019 report from the US Department of 
Health and Human Services, ideal pain care is multimodal, involving a combination of medications, 
behavioral health care, restorative therapies (e.g. physical therapy), complementary and integrative 
health, and interventional approaches (e.g. injections).12 Unfortunately, many patients do not have 
ready access to this full range of treatments. In a study of pain clinics in Michigan, 48% did not accept 
Medicaid and 51% required a referral before accepting new patients.13 Obtaining a referral could 
prove particularly difficult for a patient population that struggles to secure primary care appointments, 
as has been found of patients on LTOT.10,11 Even with an appointment, only 10% of pain clinics offered 
a combination of interventional approaches, medication management, and behavioral therapy.13 
With challenges in finding primary care doctors and limited pain care services available even with a 
referral, many patients taking opioids for chronic pain are likely not receiving appropriate, effective, 
timely, or high-quality care. 
The progression through primary care to specialty pain care can be visualized using the following 





















Figure 1. Conceptual model showing a patient’s progression through primary care, adapted from a recent qualitative 
study of patient and provider experiences.14 
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Goal
1.2 BARRIERS TO CARE
The lack of access to care arises out of the interaction between several complex and interrelated 
factors, which can be described as five overarching barriers: 
Policies
Government and payer policies around opioid prescribing add significant administrative burden 
and fear of litigation, which may reduce providers’ willingness to treat this patient population.8,15 For 
example:
 ▷ In Michigan, a provider must educate patients about possible risks, obtain a signed “Opioid 
Start Talking” form, and check the Michigan prescription drug monitoring program) before 
prescribing an opioid medication.16 The state licensing board has authority to sanction 
providers found to be in violation of state policies. 
 ▷ The largest private insurer in Michigan requires prior authorization when an opioid prescription 
exceeds a specific daily dosage threshold17 and limits opioid prescriptions to a 30-day supply.18 
(In Michigan, patients without such insurance-mandated limits can receive up to a 90-day 
supply of opioids, though federal law prohibits refills, necessitating frequent renewals.19,20)
Payment Models
Current coverage and reimbursement structures provide insufficient provider compensation 
or insurance coverage for multimodal pain management, disincentivizing the provision of 
comprehensive, effective care and restricting patient access. 
 ▷ Primary care appointments typically last less than 20 minutes.21 Providers say they do not have 
time in a primary care appointment to fully address complex issues, such as chronic pain and 
opioid management, or to coordinate multidisciplinary care.14
 ▷ Reimbursement for procedural treatments, like injections, tends to exceed reimbursement 
for physical therapy or other non-pharmacologic alternatives like massage and acupuncture. 
Furthermore non-pharmacologic alternatives can often require multiple lengthier visits. This 
incentivizes the provision of pharmacotherapy and interventional procedures,12,22 and it likely 
contributes to a workforce shortage of providers of alternative pain therapies. Moreover, many 
insurance plans do not cover alternative therapies, such as acupuncture or biofeedback, which 
are prohibitively expensive for patients to pay for out-of-pocket.23,24
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Lack of Care Coordination
A lack of coordination between providers leads to gaps in effective pain care and places additional 
burden on the patient to manage multiple opinions and treatment plans.12 
 ▷ In many care settings, pain management is not provided through a coordinated and 
multidisciplinary model. For example, specialty pain clinics are scarce in the US, and many do 
not offer multidisciplinary care.13,25 Instead, care is fragmented, multiplying the difficulty and 
cost patients face in accessing multimodal treatment. 
 ▷ Lack of provider communication may result in redundant, insufficient, or incoherent treatment 
plans.14 
Stigma
Stigma around chronic pain and substance use disorders (SUD) make it difficult for this patient 
population to find a primary care doctor or receive quality care when they do. 
 ▷ Patients with chronic pain describe providers not believing their accounts of pain26 or assuming 
that the patient is experiencing SUD, particularly when patients are taking opioids.27,28 
 ▷ Providers can be reluctant to take on patients with suspected SUD. In a multistate study, 
primary care clinics were less willing to accept a new patient taking opioids for chronic pain if 
their history was suggestive of misuse than if their previous physician retired.11 Though some 
patients do experience comorbid pain and SUD, turning patients away does not effectively 
treat either condition.     
Racial Inequities
Patients experience inequities in pain treatment depending on their race or ethnicity.29 
 ▷ Some doctors believe that there are lower pain tolerances among nonwhite patients than 
among white patients and underestimate the amount of pain that patients of color experience.30 
This is also reflected in unequal pain care: Black and Hispanic patients are less likely to 
receive opioid medication,31,32 are more likely to receive lower doses of pain medication,33 and 
experience longer wait times than white patients.34
 ▷ Non-white patients are also more likely to be perceived as “drug seeking” when pursuing pain-
related treatment,30 which likely contributes to inequities in care. Black patients, compared to 
white patients, receive more referrals for SUD assessment, fewer referrals to pain specialists, 
and increased urine drug testing,35 potentially indicating increased provider suspicions of SUD.
These overlapping barriers arise from multiple facets of the existing healthcare system. In order 
to provide more equitable and ethical care to patients taking opioids for chronic pain, these 
barriers must be considered and addressed by numerous stakeholders and participants in the 
healthcare system. To begin this process, we convened an expert panel of stakeholders from across 
the State of Michigan to generate a set of recommendations that could address these barriers and 
improve access to care for patients taking opioids for chronic pain.
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2. APPROACH
To identify possible avenues to address the above barriers, 
we convened a panel of 24 experts from across the State of 
Michigan between September 2020 and January 2021. The 
panel represented a broad range of perspectives, including 
policymakers, insurers, providers, patient advocates, and 
researchers (see full list on p. 2). Figure 2 shows each 
panelist’s primary identification. 
The panel was organized using the RAND UCLA modified 
Delphi process, which has components of both the nominal 
group technique and Delphi process.36 Due to the coronavirus 
pandemic, the panel was conducted virtually, convening for two 
synchronous meetings with background materials and surveys 
sent before and after meetings (see Figure 3). 




















Prior to the first meeting, panelists were sent two video briefs presenting 1) background information 
on barriers to multimodal care (click here to view on Youtube) and 2) possible solutions to these 
barriers that have been implemented in Michigan or elsewhere (click here to view on Youtube). They 
were also surveyed on the scope and aims of the panel. At this stage, panelists overwhelmingly 
affirmed that access to care was an important issue. They also recommended the addition of 
a specific barrier around racial inequities in care, which was not initially part of the background 
materials, and endorsed the importance of the other four identified barriers: policy, payment models, 
lack of care coordination, and stigma. 
Pilot Round
Background

























Improving Access to Care for Patients Taking Opioids
Approach -- 7
Round 1: Brainstorm
At the first meeting, the panel was divided into five groups with each group asked to brainstorm on 
one of the barriers to long-term opioid therapy (LTOT) care noted above (i.e., policy, payment models, 
lack of care coordination, stigma, and racial inequities). These sessions were facilitated by study 
team members. Each group was then asked to develop a set of recommendations related to policies, 
interventions, or research questions that would address the identified barriers to care. For each 
recommendation, the responsible group was to provide the entire panel information on: (1) how the 
recommendation would address the barrier; (2) who or what populations would the recommendation 
serve; and (3) the major challenges (e.g., feasibility, cost) or potential negative outcomes that might 
arise from implementing the recommendation.  
Following the meeting, the panel independently rated the feasibility, impact, and importance of each 
of the 15 initial recommendations on a 9-point Likert scale, with scores of 1-3 defined as a low rating, 
4-6 a moderate rating, and 7-9 a high rating. These characteristics were defined as follows: 
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Feasibility 
The extent to which a proposed recommendation is within stakeholder control and could 
attract the political and financial support necessary for implementation
Impact 
The extent to which, if implemented, a proposed recommendation would improve 
access to effective pain care for patients taking opioids for chronic pain
Importance 
The extent to which stakeholders should prioritize implementing this recommendation
Round 2: Discussion
Panelists then participated in a second virtual meeting. At this meeting, they received a list 
of all Round 1 recommendations with an average importance score of 6 or greater (n=13; 
Recommendations B and C in Appendix were excluded from further consideration). For each 
recommendation, panelists could see the distribution of scores for each critical area (i.e., 
feasibility, impact, and importance) as well as their personal rating from Round 1. They discussed 
each recommendation again, both during the second virtual meeting and on a multi-day online 
discussion board following the virtual meeting. After this round of discussion, 3 recommendations 
which overlapped in content and scope were consolidated into a single recommendation 
(see Recommendations D, F, and J in Appendix). Finally, panelists independently rated the 
final 11 recommendations on feasibility, impact, and importance a second time and ranked all 
recommendations in order of implementation priority.  
Upon completion of the final rating and ranking, the research team noted similarities in the objectives 
and mechanisms of the 11 final recommendations and grouped them into three thematic domains. 
To describe the relative prioritization of these three thematic domains, the research team pooled and 
averaged all panelist rankings for the recommendations within each theme. 
3. PANEL RECOMMENDATIONS AND FEEDBACK
The panel ultimately generated 11 recommendations that could potentially improve access to care 
(see Table 1). The panelists’ median scores of recommendation feasibility ranged from 5.5 - 7, 
impact from 5 - 8, and importance from 5.5 - 9. All median scores fell at or above the midpoint of the 
rating scale (5), which suggests that the panel considered all recommendations to be moderately 
to very feasible, impactful, and important. The panelists’ priority rankings for each recommendation 
were averaged to yield the final ranked list, and recommendations were grouped into three thematic 
domains (see thematic groupings in Table 1 on the following page):
Improving care models to better support patients with chronic pain
Three recommendations involved improving care models, including the top two: 
increasing reimbursement for time needed to treat complex chronic pain (#1) and 
establishing coordinated care models that bundle payments for multimodal pain 
treatment (#2). On average, recommendations in this theme received the highest 
priority rankings (pooled average rank = 4.2/11).
Enhancing provider education and training
Four recommendations focused on provider education and included training on 
biopsychosocial factors of pain care (#3) and clarifying the continuum between 
physical dependency and opioid use disorder (#5). These recommendations 
received slightly lower priority rankings (pooled average rank = 6.2/11).
Implementing practices to reduce racial biases and inequities
The remaining four recommendations address racial biases and inequities 
(pooled average rank = 7.2/11), ranging from standardizing pain management 
protocols to reduce bias (#7) to increasing recruitment and retention of providers 
from underrepresented racial minorities (#8).








Establish reimbursement models for chronic pain to provide 
appropriate compensation for all care providers, such as 
psychologists, physical therapists, physician assistants, nurse 
practitioners, social workers, and physicians, who treat and manage 
patients with complex pain.
Create a collaborative/integrated care model expanding upon the 
existing Michigan Medicaid Health Home model to include patients 
with chronic pain who are publicly and privately insured.
Train members of the clinical team, such as social workers, to help 
address biopsychosocial factors and ongoing management of chronic 
pain treatment.
Improve dissemination of evidence related to multimodal and non-
pharmacological treatments for pain and their effectiveness to 
encourage expanded insurance coverage.
Deliver an educational curriculum that explains the continuum between 
addiction and physical dependency on long-term opioid therapy for 
chronic pain to all personnel who interact with patients (providers, 
clerical staff, etc.) to encourage appropriate patient-centered care and 
reduce stigma.
Improve education on multimodal and non-pharmacological therapies 
for chronic pain management (and chronic pain in general) for 
healthcare providers, including both at the level of health professional 
school and continuing medical education.
Implement standardized pain management protocols that include 
mandatory reporting to provide more objective data on pain 
management across races and ethnicities.
Increase recruitment and retention of providers from underrepresented 
racial and ethnic minorities across clinical duties (e.g., physicians, 
nurse practitioners, social workers) including by providing appropriate 
financial compensation and incentives if practicing in under-resourced 
communities.
Make providers aware of how Michigan's prescription drug monitoring 
program data is used in investigating and disciplining providers.
Develop implicit bias training to improve patient-provider 
communication around pain.
Evaluate and describe where individuals belonging to minority racial 
and ethnic groups prefer to receive health-related information and 












































Table 1. Final list of recommendations in order of priority ranking, with median ratings of feasibility, 
impact, and importance. Colors indicate thematic domain as follows:
Blue: Improving care models Yellow: Provider education Orange: Addressing racial bias and inequities
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3.2 RANKINGS
3.2 DETAILED DESCRIPTIONS AND DISCUSSION SUMMARIES
Recommendations are described in greater detail below, including a one-sentence overview, a more 
detailed recommendation description that panelists collaboratively generated, and a researcher-
written summary of the panel’s discussion. The language of each recommendation summary and 
description was developed through iterative discussions and reflects the collective perspective and 
expertise of the panel. Expert panel discussion summaries provide information about the main topics 
considered while the panel created and reviewed each recommendation.
Establish reimbursement models for chronic pain to provide appropriate 
compensation for all care providers, such as psychologists, physical 
therapists, physician assistants, nurse practitioners, social workers, and 
physicians, who treat and manage patients with complex pain.
1
Detailed Description: Visits for chronic pain are often complex and require significantly 
more clinical time than other conditions. Currently, members of pain-related care teams (e.g. 
clinical pharmacists, nurses, social workers) do not receive reimbursement specifically for their 
services, and physicians and other billable providers can be reluctant to manage patients with 
chronic pain because it is so time-intensive. Different reimbursement models, such as value-
based reimbursement and billing modifiers, may incentivize the provision of time-intensive and 
personnel-intensive care, from both physicians and other care team members, and lead to 
increased access to quality, full-team care.
Discussion Summary: During the panel discussion, there was some concern about the difficulty 
of reaching a common understanding of what types of coverage increased “value” and that the 
meaning of “value” could differ between stakeholder groups (e.g. patients and insurers). Similarly, 
some panelists thought insurers might be reluctant to increase reimbursement due to the cost or 
would want robust evidence of cost-effectiveness. Interestingly, panelists with insurance expertise 
were more confident than other panelists that insurers would, in fact, be willing to shift their 
existing reimbursement structures to drive provider behavior change.
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Train members of the clinical team, such as social workers, to help 
address biopsychosocial factors and ongoing management of chronic 
pain treatment.
3
Detailed Description: This would address prescriber concerns about being unable to adequately 
support and monitor patients using long-term opioid therapy from a physical and mental 
health perspective. These additional staff would provide support for ongoing pharmacologic 
treatments, such as opioid therapy, as well as non-pharmacologic treatments, such as behavioral 
interventions. When appropriate, these team members could also identify and refer patients to 
address issues such as housing and behavioral health concerns. 
Discussion Summary: Panelists did note that training and, where necessary, hiring these staff 
members could pose a challenge to implementation, particularly within existing reimbursement 
models that do not typically cover such assistance. Therefore, this recommendation is closely 
related to Recommendation #1 in that the staff, once trained in managing biopsychosocial 
factors, must also be reimbursed for their time.  
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Create a collaborative/integrated care model expanding upon the 
existing Michigan Medicaid Health Home model to include patients with 
chronic pain who are publicly and privately insured.
2
Detailed Description: Currently, patients may not be encouraged to pursue non-pharmacologic 
treatment modalities or be counseled on whether opioid medications are effective or safe long 
term (tolerance/dependence). In the existing Michigan Medicaid Opioid Health Home model, 
which is funded through Michigan Medicaid and focused on treating patients with opioid use 
disorder (OUD), patients are provided intensive support, including case management (for more 
information on Michigan Opioid Health Homes, click on this link). Patients are presented with 
all available resources and treatment options at one time and provided support in navigating 
integrated care across multidisciplinary providers (e.g. transitional care and referral to community 
and social services). Interested health systems and providers can apply for Health Home 
designation status to receive funding to support these staff, such as a director, behavioral health 
specialist, and peer recovery coach. The panel recommended expanding the existing model in 
Michigan to include patients with chronic pain, which has been included as a qualifying condition 
for Medicaid-funded health home care models in at least 5 states (Iowa, Missouri, New York, 
South Dakota, and Washington).37,38 This would ensure that these multimodal therapies are easily 
accessible before the patient becomes physically dependent on opioids.
Discussion Summary: Panelists noted that private payers could fund similar structures to expand 
this care model further. Noted challenges with this recommendation included securing funding 
from public or private insurers, having an adequate workforce to staff the model, and needing 
different types of providers in a care team (e.g. physical therapists) to provide pain-focused care 
that the current OUD-focused model does not utilize.
Deliver an educational curriculum that explains the continuum between 
addiction and physical dependency on long-term opioid therapy for chronic 
pain to all personnel who interact with patients (providers, clerical staff, etc.) 
in order to encourage appropriate patient-centered care and reduce stigma.
5
Detailed Description: Providers, staff, and even patients may equate prescribed opioid 
treatment with addiction because of a lack of knowledge about the differences between addiction 
and physical dependence. Some providers who prescribe opioids appropriately have suggested 
that they feel stigmatized or judged by their colleagues. Within electronic medical records 
systems, patients prescribed long-term opioid therapy may incorrectly be labeled as having an 
opioid use disorder (OUD). An educational intervention that explains the differences between 
physical dependence and addiction and the harms of incorrect assumptions can address these 
stigmatizing ideas. This could also clarify best practices for patients who have comorbid OUD and 
chronic pain. 
Discussion Summary: There was some concern among panelists that this type of educational 
intervention could be too simplistic, and, in trying to categorize patients as having either pain or 
OUD, ultimately further stigmatize patients with OUD. This stigma could then potentially manifest, 
counterproductively, as worse pain care for patients who have both pain and OUD. Furthermore, 
panelists acknowledged that it can be challenging to develop and implement effective educational 
campaigns that reduce provider stigma and change behavior.   
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Improve dissemination of evidence related to multimodal and non-
pharmacological treatments for pain and their effectiveness to 
encourage expanded insurance coverage.
4
Detailed Description: Insurers are more likely to provide coverage and increase reimbursement 
for services that are evidence-based and cost-effective. Therefore the objective of this 
recommendation is to disseminate information regarding the efficacy of multimodal and non-
pharmacologic treatments to insurers to potentially improve coverage for such treatments.
Discussion Summary: Initially, there was some disagreement among panelists as to whether 
evidence of treatment effectiveness already exists in systematic reviews and whether the 
existing data is robust. However, upon further discussion, there was agreement that the existing 
evidence base needs to be conveyed to insurance companies to inform coverage changes. 
There was some concern that some non-pharmacological treatment modalities can be quite 
expensive, and insurers may be unwilling to cover these high-cost treatments even with evidence 
of effectiveness. Similarly, panelists voiced hesitancy about the transparency of insurers’ cost-
effectiveness determinations. Finally, several panelists brought up persistent disbelief among 
providers as to the effectiveness of these treatments, which could potentially limit engagement 
even with increased coverage. Ultimately panelists felt that there may be a knowledge gap more 
so than a lack of evidence for such treatments, and the evidence therefore needs to be relayed to 
insurers to encourage expanded coverage. 
Implement standardized pain management protocols that include 
mandatory reporting to provide more objective data on pain management 
across races and ethnicities.
7
Detailed Description: Systematic protocols, such as screening and management checklists, 
may reduce individual provider biases in pain treatment and variation across providers. 
Mandatory reporting of treatment data may increase data transparency with respect to racial 
outcomes and demonstrate potential areas for improvement. 
Discussion Summary: Panelists noted that developing and implementing these protocols 
would require financial resources, and it can be challenging to design protocols that are directive 
enough to provide consistent care without being so rigid as to be misapplied in inappropriate 
treatment situations. 
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Improve education on multimodal and non-pharmacological 
therapies for chronic pain management (and chronic pain in general) 
for healthcare providers, including both at the level of health 
professional school and continuing medical education.
6
Detailed Description: Providers may not have a solid understanding of the efficacy of non-
pharmacological treatments and how to guide patients towards these treatments. By educating 
providers on how to diagnose chronic pain, the treatment options, and how to use them 
effectively, more treatment modalities could be provided in more care settings outside of specialty 
pain clinics. This educational intervention would not only apply to physicians but to all members 
of the care team. This could help address misconceptions and stigma about patients with chronic 
pain, especially around disbelief of pain or assumptions of addiction.
Discussion Summary: Panelists did note that these existing attitudes and misconceptions 
are deeply entrenched and could be difficult to overcome. Also, it could be difficult to design 
effective and comprehensive curricula because pain management is often quite complex and 
individualized. 
Make providers aware of how Michigan's prescription drug monitoring 
program data is used in investigating and disciplining providers.9
Detailed Description: Michigan’s prescription drug monitoring program is an online database 
providers use to keep track of prescriptions for controlled substances. There is currently 
confusion about how and when prescription data are used to investigate and possibly sanction 
providers. Both physicians and patients have noted that providers are fearful of being sanctioned 
for prescribing opioids. By clarifying when and how prescription data are actually used in 
licensing investigations, an awareness campaign may reduce provider fears of sanction, 
and therefore reduce inappropriate under-prescribing. This awareness intervention will focus 
specifically on how this data is monitored with respect to legal consequences for providers 
and not be focused on general use of the platform. Reducing provider reluctance to treat this 
population will consequently increase access to providers for patients receiving long-term opioid 
therapy. 
Discussion Summary: Some panelists felt that this would not be effective because there 
has already been extensive provider training about how to use Michigan's prescription drug 
monitoring program, and additional efforts to clarify its use could add administrative burdens to 
prescribing, further limiting patient access to care. It is also unclear whether increased awareness 
around actual data use would change provider perceptions about the legal ramifications of opioid 
prescribing or consequent willingness to prescribe. 
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Increase recruitment and retention of providers from underrepresented 
racial and ethnic minorities across clinical duties (e.g., physicians, nurse 
practitioners, social workers) including by providing appropriate financial 
compensation and incentives if practicing in under-resourced communities.
8
Detailed Description: Patients from minority racial and ethnic groups often feel more 
comfortable and experience less racial discrimination when treated by a provider of the same 
race. However, there is concern about the limited representation of racial minorities among 
providers who treat this patient population. This problem is multifactorial and includes both 
recruitment of people from underrepresented racial minority groups into health professional 
programs and retention of health professionals from underrepresented racial minorities working 
in areas with limited healthcare resources. This would be addressed by first recruiting more 
providers from underrepresented racial minorities into health professional programs. Once 
trained, it would also be important to support and incentivize these providers to practice in 
communities that face racial bias and disparities in care.
Discussion Summary: Panelists noted that it could be challenging to secure consistent funding 
for incentive programs, and the effectiveness of recruitment efforts could be limited by ongoing 
disputes over affirmative action. 
Evaluate and describe where individuals belonging to minority 
racial and ethnic groups prefer to receive health-related 
information and community institutions they look to for support 
in healthcare decisions.
11
Detailed Description: As a first step to improve healthcare engagement with racial and ethnic 
minority communities with limited access to healthcare resources, more research is needed to 
identify trusted anchor institutions and preferred information delivery mechanisms. With this data, 
community outreach and treatment education efforts can then be tied to and focused on these 
trusted institutions (e.g churches). 
Discussion Summary: Panelists noted this type of data could be challenging to collect, and both 
the initial research and any resulting implementation strategies would require funding. There was 
some disagreement among panelists as to whether the initial evaluation of how to disseminate 
healthcare-related information was necessary. Some argued that funding should instead be 
invested directly into engagement efforts, and that there was already sufficient information about 
effective engagement channels.  
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Develop implicit bias training to improve patient-provider 
communication around pain.10
Detailed Description: Implicit bias training would help address cultural barriers in patient-
provider communication. Reducing provider bias and improving communication may make health 
services seem more accessible to patients from racial and ethnic minority groups, and may 
thereby improve treatment outcomes.
Discussion Summary: Panelists recognized that these trainings can become a “checkbox” 
for organizations, and may not be effective in their implementation or intended outcomes. Also, 
developing and implementing these trainings would require an investment of health system 
resources. 
4. DISCUSSION
As stakeholders consider these recommendations, it is worth noting that policies and interventions 
similar to those the panel recommended have been implemented in other contexts. Examples are 
provided below: 
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Improving care models to better support patients with chronic pain
Enhancing provider education and training
Implementing practices to reduce racial biases and inequities
On restructuring care models, five states—Iowa, Missouri, New York, South Dakota, and 
Washington—currently list some type of chronic pain as a qualifying condition for their 
Medicaid Health Homes, granting patients in those states access to a more coordinated 
care model.37,38 Colorado has increased Medicaid coverage of non-opioid pain 
management, including by increasing reimbursement rates for physical therapy, which 
led to more physical therapists accepting Medicaid and more physical therapy services 
rendered to patients.39 Oregon has added coverage for acupuncture, chiropractic 
services, osteopathic manipulation, cognitive behavioral therapy, and physical 
therapy for Medicaid beneficiaries with back and neck pain, affecting approximately 
50,000 Oregonians.40 In Michigan, private insurers have used modifiers, a billing 
increase tied to providing “additional” care, to drive provider behavior change around 
opioid prescribing. Blue Cross Blue Shield of Michigan successfully used this tool to 
encourage surgeons to counsel patients about opioid pain management and prescribe 
fewer opioids after surgery. The program resulted in surgeons counseling patients and 
reducing opioid prescribing in 70% of eligible surgeries.41 It is possible private insurer 
modifiers may also be used to reorient chronic pain care to better align with evidence-
based multimodal treatment approaches.
In the realm of provider education, many states, including Michigan, already mandate 
continuing medical education credits in pain management for maintaining licensure, 
though qualifying trainings are often limited in scope and duration, emphasizing 
addiction risks and providing little guidance on multimodal care.42 At the health 
professional school level, medical schools in the United States have historically offered 
very limited pain care curricula,43 though several medical schools, such as Johns 
Hopkins and the University of Washington,44,45 have recently increased their curricular 
offerings around pain management in recognition of this educational gap. 
To address racial inequities in health care, Michigan’s Department of Licensing and 
Regulatory Affairs has just instituted a new rule mandating 1 hour of implicit bias training 
per year for healthcare professional licensure.46 However, this new implicit bias training 
requirement is not specific to pain- or addiction-related care, and, as the requirement 
has not yet gone into effect, its impact on pain-related care remains to be seen. A 
recent study indicated that personally-tailored implicit bias training can reduce racial 
biases in chronic pain treatment by engaging providers in perspective-taking exercises 
(e.g. imagining the impact pain has on a patient’s life) with real-time feedback.47 At the 
federal level, the Biden administration recently announced its intention to address racial 
inequities in substance use disorder treatment, including by identifying data gaps to 
target unmet treatment needs and identifying culturally competent and evidence-based 
practices, but these priorities have not yet been enacted, and they do not encompass 
inequities in pain care.48 Regardless, these existing efforts provide valuable context 
for possible future efforts to address racial inequities in care, both in Michigan and 
elsewhere. 
5. CONCLUSION
Our multidisciplinary stakeholder panel felt that improving access to care for patients taking opioids 
for chronic pain is a pressing, complex issue. Patients’ access is limited by five overlapping barriers: 
policies, payment models, a lack of care coordination, stigma, and racial bias and inequities. The 
panel generated 11 final recommendations to address the different facets of this issue, concluding 
that numerous possible solutions could and ought to be implemented. Broadly, their recommendations 
encourage implementing new care models for chronic pain, enhancing provider education and 
training, and addressing racial biases and inequities in care. We hope these findings provide valuable 
guidance to stakeholders and policymakers, both in Michigan and elsewhere, as they work to improve 
access to care for this population. 
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Importantly, though this panel was convened in Michigan, and its expertise grounded in Michigan’s 
healthcare ecosystem, there are millions of patients taking opioids for chronic pain across the country, 
and reports of limited access to care are not unique to Michigan. Consequently, there may also be 
opportunity to apply these recommendations more broadly, in other states and at multiple levels of the 
United States healthcare system. Indeed, panelists consistently emphasized that, because the lack of 
access to care arises out of so many contributing causes, there are correspondingly many options for 
a wide range of stakeholders to improve it. 
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APPENDIX
Original 15 recommendations following  Round 1 meeting. Note that Recommendations B and C 
were removed from consideration before Round 2, and Recommendations D, F, and J were ultimately 
combined into a single recommendation. 
A. Educate providers about how the Michigan Automated Prescription System (MAPS) data is used 
in investigating and disciplining providers.
B. Enact legislation to separate information in MAPS regarding patients with acute pain vs. chronic 
pain in order to reduce the administrative burden of current MAPS policies.
C. Educate pharmacists about opioid prescribing policies and limits to reduce uncertainty and 
differences in care between pharmacies.
D. Establish value-based care models for chronic pain, with appropriate compensation for the 
physicians and care teams who treat and manage patients with complex pain.
E. Conduct and disseminate a systematic review of evidence related to non-pharmacological 
treatments for pain and their efficacy.
F. Incentivize providers through payment reform (e.g., insurance payments) to educate patients on 
the disease progression of chronic pain to facilitate reaching a treatment plan.
G. Create a collaborative/integrated care model expanding upon the existing Michigan Medicaid 
Health Home model to include patients with chronic pain who are publicly and privately insured.
H. Improve education on multimodal therapies for chronic pain management (and chronic pain in 
general) earlier on in the education of healthcare providers, at the level of health professional 
school.
I. Deliver an educational curriculum that explains differences between addiction and physical 
dependency on long-term opioid therapy for chronic pain to all personnel who interact with 
patients (providers, clerical staff, etc.).
J. Increase reimbursement for evaluating patients with chronic pain across provider types (e.g. MDs 
and advanced practice providers (APPs), such as physician assistants and nurse practitioners).
K. Train members of the clinical team, such as social workers, to help address biopsychosocial 
factors and ongoing management of chronic pain treatment.
L. Increase recruitment and retention of providers of color across clinical duties (e.g., MD, NP, SWs) 
especially in underserved communities.
M. Implement standardized pain management protocols that include mandatory reporting to provide 
more objective data on pain management across races and ethnicities.
N. Develop implicit bias training to improve patient-provider communication around pain.
O. Evaluate and describe where BIPOC individuals prefer to receive health-related information, and 
community institutions they look to for support in healthcare decisions.
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